CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q3 2023. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,444 | +1.9% | 36,358 | +84.0% | 0.00% | +33.3% |
| Q2 2023 | $66,196 | +130.1% | 19,760 | +88.2% | 0.00% | +50.0% |
| Q1 2023 | $28,765 | -51.6% | 10,498 | -31.0% | 0.00% | -50.0% |
| Q4 2022 | $59,452 | +197.3% | 15,205 | +15.3% | 0.00% | +300.0% |
| Q3 2022 | $20,000 | -25.9% | 13,184 | +11.6% | 0.00% | -50.0% |
| Q2 2022 | $27,000 | -3.6% | 11,813 | -4.9% | 0.00% | 0.0% |
| Q1 2022 | $28,000 | – | 12,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |